Elgaard, Cathrine Dawn Büttner http://orcid.org/0000-0003-1965-4242
Iversen, Lars http://orcid.org/0000-0003-1816-4508
Hjuler, Kasper Fjellhaugen http://orcid.org/0000-0001-6082-5096
Article History
Accepted: 3 April 2023
First Online: 8 May 2023
Declarations
:
: None.
: Cathrine Elgaard has received a personal scholarship from Novo Nordisk Foundation outside of the submitted work. Dr Iversen is employed by MC2 Therapeutics A/S and has served as a consultant and/or paid speaker for and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Astra Zeneca, BMS, Boehringer Ingelheim, Celgene, Centocor, Eli Lilly, Janssen Cilag, Kyowa, Leo Pharma, MSD, Novartis, Pfizer, Regranion, Samsung and Union Therapeutics UCB. Dr Hjuler has served as a consultant and advisor for the following companies: AbbVie, Bristol Myers Squibb (BMS), Janssen, LEO Pharma, UCB and Novartis, and has received speaking fees or grants from AbbVie, Eli Lilly, LEO Pharma, Novartis and Janssen.
: This project was reviewed and approved by the administration of Aarhus University Hospital. In Denmark, register studies require no approval from an ethics committee. The study complied with the Declaration of Helsinki.
: Not applicable. In Denmark, register studies require no informed consent according to the Danish Health Care Act, § 42 d, section 2 (2022).
: Not applicable.
: The datasets generated during the current study are available from the corresponding author on reasonable request.
: The dataset generated during the current study is available from the corresponding author on reasonable request.
: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship. Concept and design: KFH. Acquisition, analysis, or interpretation of data: CDBE, KFH. Drafting of the manuscript: CDBE. Critical revision of the manuscript for important intellectual content: CDBE, LI, KFH. Statistical analysis: CDBE. Administrative, technical, or material support: LI. Supervision: KFH. All authors read and approved the final manuscript.